pyridostigmine bromide has been researched along with albuterol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Arvat, E; Camanni, F; Ghigo, E; Gianotti, L; Maccario, M; Ramunni, J | 1 |
| Beeson, D; Belaya, K; Burke, G; Cossins, J; Finlayson, S; Holton, JL; Norwood, F; Palace, J; Pascual-Pascual, SI; Walls, TJ | 1 |
| Moss, JI | 1 |
| Beeson, D; Cetin, H; Cheung, J; Cossins, J; Liu, WW; Maxwell, S; Palace, J; Ramjattan, H; Rodriguez Cruz, PM; Vanhaesebrouck, AE; Webster, R; Wickens, J | 1 |
1 trial(s) available for pyridostigmine bromide and albuterol
| Article | Year |
|---|---|
Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans.
Topics: Adult; Albuterol; Arginine; Depression, Chemical; Drug Synergism; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Immunoradiometric Assay; Male; Pyridostigmine Bromide; Random Allocation | 1994 |
5 other study(ies) available for pyridostigmine bromide and albuterol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
Topics: 4-Aminopyridine; Adrenergic beta-2 Receptor Agonists; Adult; Age of Onset; Albuterol; Amifampridine; Biopsy; Cholinesterase Inhibitors; Diagnosis, Differential; DNA Mutational Analysis; Exome; Female; Genetic Testing; Glycosylation; Humans; Male; Middle Aged; Motor Neurons; Muscle, Skeletal; Myasthenic Syndromes, Congenital; N-Acetylglucosaminyltransferases; Neurologic Examination; Neuromuscular Junction; Phenotype; Potassium Channel Blockers; Pyridostigmine Bromide | 2013 |
Gulf War illnesses are autoimmune illnesses caused by increased activity of the p38/MAPK pathway in CD4+ immune system cells, which was caused by nerve agent prophylaxis and adrenergic load.
Topics: Albuterol; Animals; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Humans; MAP Kinase Signaling System; Mice; Models, Biological; Persian Gulf Syndrome; Pyridostigmine Bromide; Sodium Chloride; Th17 Cells | 2013 |
β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
Topics: Action Potentials; Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Humans; Mice; Myasthenic Syndromes, Congenital; Neuromuscular Junction; Pyridostigmine Bromide; Synaptic Transmission | 2019 |